Rescuing clinical trials in the United States and beyond: A call for action
Clinical Trials Friday, March 22nd, 2013American Heart Journal: March 13, 2013
Numerous challenges—financial, regulatory, and cultural—are hindering US participation and performance in multinational clinical trials. Consequently, it is increasingly unclear how the results of these trials should be applied to American patients, practice patterns, and systems of care. Both incremental and transformative changes are needed to revitalize US participation as well as the broader clinical trial enterprise. Read more
